PIN1 and breast carcinoma: This cross-talk appears to be relevant for morphogenetic processes such as expansion of the mammary gland during pregnancy, while in breast cancers with high levels of PIN1, it confers resistance to selective estrogen receptor modulators, such as tamoxifen (81).